Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - March 2012


Adaptive Designs in Clinical Drug Development

26 Mar 2012 - 27 Mar 2012 - London, UK



Bookmark and Share


‘Buying in’ to adaptive design trials: strategies and methods for implementing successful adaptive design studies Monday 26th & Tuesday 27th March 2012, Grange Holborn, London
SMi are proud to present the 6th Annual Adaptive Designs in Clinical Drug Development conference, following on from SMi’s previous highly successful Adaptive Designs events and offers the opportunity to keep up-to-date with the latest challenges and solutions essential for successful and cost-effective adaptive clinical trials.
In recent years, the use of adaptive design in clinical trials has been considered an efficient and optimal way of designing clinical trials.  Adaptive design has gradually evolved from a novel idea into a standard norm in the pharmaceutical industry. This new clinical paradigm could change the way traditional clinical trials, with their restrictive guidance, are run today.
With more flexibility, faster development timelines and significant monetary savings, an adaptive design trial is the way forward.
The conference will address adaptive clinical trials for rare disease medicine development. The agenda will not only tackle issues surrounding effective management of your adaptive design in clinical trials but the increasing use of Bayesian modelling and using adaptive designs in early clinical trials. As adaptive designs are recently gradually evolving from a novel idea into a standard norm in the pharmaceuticals industry, industry leaders are asking themselves whether to adapt or not to adapt.

Key Reasons to attend Adaptive Designs in Clinical Drug Development;
•    Learn how to maximise the benefits of an adaptive design through effective management
•    Develop your knowledge of the adaptive designs. From start to end, it is important to know everything about adaptive clinical trials to gain maximum advantage.
•    Understand the challenges of the high-density biomarker adaptive trial.
•    Discover what the future holds in this rapidly evolving market and the impact of new regulation and technology.
•    Improve your clinical trials in early phases to reduce costs and time.
•    Evolve your understanding of current technologies to protect trial integrity, reduce operational bias and build regulatory confidence.
•    Network with key industry professionals
Visit the website to register: http://www.smi-online.co.uk/2012adaptivedesigns9.asp
Alternatively or contact Shilan Chandi on: +44 (0)20 7827 6738 e-mail: schandi@smi-online.co.uk



Further information
Scientific News
Big Genetics in BC: The American Society for Human Genetics 2016 Meeting
Themes at this year's meeting ranged from the verification, validation, and sharing of data, to the translation of laboratory findings into actionable clinical results.
Stem Cells in Drug Discovery
Potential Source of Unlimited Human Test Cells, but Roadblocks Remain.
Automated Low Volume Dispensing Trends
Gain a better understanding of the current and future market requirements for fully automated LVD systems.
Cancer Genetics: Key to Diagnosis, Therapy
When applied judiciously, cancer genetics directs caregivers to the right drug at the right time, while sparing patients of unnecessary or harmful treatments.
Major Neuroscience Initiative Launched
Tianqiao and Chrissy Chen Institute invest $115 million to further expand neuroscience research, while Caltech construct $200 million biosciences complex.
Diabetes Missing Link Discovered
Researchers from the University of Auckland have shown that beta catenin plays a vital role in the control of insulin release from the pancreas.
Study Reveals New Role for Hippo Pathway in Suppressing Cancer Immunity
Hippo pathway signaling regulates organ size by moderating cell growth, apoptosis and stem cell renewal, but dysregulation contributes to cancer development.
Ribosome Recycling as a Drug Target
Researchers explain mechanism that recycles bacterial ribosomes stalled on messenger RNAs that lack termination codons.
How the Brain Recognizes Faces
Machine-learning system spontaneously reproduces aspects of human neurology.
Boosting Effectiveness of Asthma Therapy
A team of scientists from UCSF has developed a new treatment to dampen bronchospasm.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!